VIVOTEK's consolidated sales revenues for March 2025 totaled USD $21.43 million, representing a 25 percent increase as compared to USD $17.15 million for February 2025 and a 9 percent increase as compared to USD 19.62 million for March 2024.

The Company's cumulative consolidated sales revenues from January to March in 2025 were USD $58.77 million, a 18 percent increase as compared to USD $49.84 million for the same period in 2024.